BOWERS WILLIAM P reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director William P. Bowers reported a compensation-related award of deferred phantom share equivalents tied to Exelon common stock. He received 925 phantom share equivalents at a reference value of $46.62 per share, increasing his balance in the Exelon stock fund account to 21,266 equivalents.
These phantom share equivalents are part of a multi-fund, non-qualified deferred compensation plan and will be settled in cash on a 1-for-1 basis after his service on the board ends. The reported balance also reflects 183 additional phantom share equivalents that accrued automatically through dividend reinvestment, indicating this is a cash-settled, deferred arrangement rather than an open-market stock purchase or sale.
Exelon Corporation and its utility subsidiaries reported solid Q1 2026 results, with consolidated operating revenues of $7,242 million compared with $6,714 million a year earlier. Net income attributable to common shareholders was $919 million, essentially flat versus $908 million, and diluted earnings per share held at $0.90.
Operating cash flow strengthened to $1,724 million from $1,200 million, while capital expenditures increased to $2,358 million, reflecting ongoing grid and infrastructure investment. Total assets were $117,545 million and long‑term debt was $47,859 million as of March 31, 2026.
Among the utilities, ComEd, PECO, BGE, Pepco, DPL and ACE all remained profitable, with BGE earning $298 million, PECO $278 million and Pepco Holdings $169 million. ACE also recorded a prior-period rate classification error correction that reduced Q1 2026 net income by $10 million, which management deemed not material.
Exelon Corporation reported first quarter 2026 GAAP earnings of $0.90 per share, unchanged from a year ago, and Adjusted (non-GAAP) operating earnings of $0.91 per share, down from $0.92. Consolidated operating revenues were $7.24 billion, up from $6.71 billion, as its utilities benefited from higher approved distribution and transmission rates, favorable weather at some units, and the absence of PECO customer surcharge credits, partly offset by higher depreciation, interest expense, and credit loss costs.
By utility, ComEd, PECO and BGE grew GAAP net income to $310 million, $278 million and $298 million, while PHI declined to $169 million due to a Pepco Maryland multi-year plan reconciliation and higher depreciation. Exelon affirmed full-year 2026 Adjusted operating earnings guidance of $2.81–$2.91 per share and continues to target Adjusted EPS compound growth near the top end of 5–7% from 2025 to 2029.
The company outlined a revised four‑year capital plan of $41.7 billion, supporting expected rate base growth of 7.9% and significant transmission investment. Operating cash flow rose to $1.72 billion, and the board declared a quarterly dividend of $0.42 per share. Management highlighted sustained top‑quartile reliability, progress on large-load transmission security agreements, and completion or pricing of a substantial portion of planned 2026 debt and longer-term equity financing.
Exelon Corporation reported the results of its Annual Meeting of Shareholders held on April 28, 2026. Shareholders of record as of March 2, 2026, were entitled to vote.
All nominated directors were elected, each receiving at least 92.8% of votes cast in favor. For example, Calvin G. Butler, Jr. received 840,779,094 votes for, or 99.2% of votes cast. Auditor ratification for 2026 passed, with 818,550,440 votes for, or 89.0% of votes cast, approving PricewaterhouseCoopers LLP as independent auditor. An advisory vote on executive compensation also passed, receiving 764,185,640 votes for, or 90.5% of votes cast.
Exelon Corp ownership filing: Vanguard Capital Management reports beneficial ownership of 76,934,260 shares of Exelon common stock, representing 7.51% of the class. The filing states Vanguard has sole voting power over 10,918,572 shares and sole dispositive power over 76,934,260 shares. The disclosure attributes holdings across Vanguard Capital Management LLC and affiliated business divisions per SEC Release No. 34-39538.
Segedi Bryan K reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Bryan K. Segedi received a grant of 3,720 2026 Directors Restricted Stock Units (RSUs). These RSUs were awarded at no cash cost as part of the Exelon Long-term Incentive Plan.
The RSUs will fully vest and be settled on a 1-for-1 basis into Exelon common stock on April 28, 2027. Additional stock units will accrue through dividend reinvestment and will vest at the same time as the underlying award. Following this grant, Segedi holds 3,720 RSUs linked to Exelon common stock.
Exelon Corp director Matthew C. Rogers received an annual equity award of 3,720 restricted stock units for 2026 board service. These 2026 Directors Restricted Stock Units were granted at a $0.00 exercise price under the Exelon Long-term Incentive Plan and will fully vest and be settled in Exelon common shares on a 1-for-1 basis on April 28, 2027. The award will accumulate additional stock units through dividend reinvestment that vest with the underlying grant.
The filing also notes 739 deferred phantom share equivalents tied to Exelon common stock in a non-qualified deferred compensation plan. These phantom share equivalents are settled in cash on a 1-for-1 basis when Rogers’ service on Exelon’s board ends, rather than through open-market stock transactions.
RICHO ANNA reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Anna Richo reported a compensation-related equity grant and updated deferred holdings. She received 3,720 "2026 Directors Restricted Stock Units" on April 28, 2026, which are scheduled to fully vest and be settled in Exelon common stock on a 1-for-1 basis on April 28, 2027 under the Exelon Long-term Incentive Plan.
The filing also shows 7,930 deferred phantom share equivalents in a non-qualified deferred compensation plan, each linked 1-for-1 to Exelon common stock and payable in cash after her service on the board ends. No open-market buys or sells are reported in this filing.
Lillie Charisse R reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Charisse R. Lillie reported an annual equity award and deferred compensation holdings. On April 28, 2026, she received 3,720 2026 Directors Restricted Stock Units under Exelon’s Long-term Incentive Plan, vesting and settling in common stock on a 1-for-1 basis in 2027. She also holds 3,855 deferred phantom share equivalents in a non-qualified deferred compensation plan, payable in cash on a 1-for-1 basis after her service on the board ends.
Jojo Linda P reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Linda P. Jojo received a grant of restricted stock units under the Exelon Long-term Incentive Plan. On April 28, 2026, she was awarded 3,720 2026 Directors Restricted Stock Units at a price of $0.00 per unit as compensation, not an open-market purchase.
The RSUs are scheduled to fully vest on April 28, 2027 and will be settled in an equal number of Exelon common shares on a 1-for-1 basis. The award will also accrue additional stock units through dividend reinvestment, which will vest at the same time as the underlying grant.